Trastuzumab: A Viewpoint by Mark Pegram

By Pegram M.  

BioDrugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 136-138

Adis International

Access to resources Recommend Favorite

HER-2-Positive Breast Cancer: Hope Beyond Trastuzumab

By Bartsch Rupert   Wenzel Catharina   Zielinski Christoph C.   Steger Guenther G.  

BioDrugs, Vol. 21, Iss. 2, 2007-01 ,pp. : 69-77

Adis International

Access to resources Recommend Favorite

Trastuzumab in HER2-Positive Metastatic Gastric Cancer†: Profile Report

By Croxtall Jamie D.   McKeage Kate  

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 257-259

Adis International

Access to resources Recommend Favorite

Spotlight on Trastuzumab in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer

By Plosker Greg L.   Keam Susan J.  

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 259-262

Adis International

Access to resources Recommend Favorite

Spotlight on Trastuzumab as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer†

By Garnock-Jones Karly P.   Keating Gillian M.   Scott Lesley J.  

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 207-209

Adis International

Access to resources Recommend Favorite